Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair

PURPOSE: Generally, aspirin is used as a protective agent against thrombogenic phenomenon after pulmonary valve replacement (PVR) using a bioprosthetic valve. However, the appropriate duration of aspirin use is unclear. We analyzed the impact of postoperative duration of aspirin use on the longevity...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Tae-Woong, Kim, Sung-Ook, Lee, Sang-Yun, Kim, Seong-Ho, Choi, Eun-Young, Jang, So-Ick, Park, Su-Jin, Kwon, Hye-Won, Lim, Hyo-Bin, Lee, Chang-Ha, Choi, Eun-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pediatric Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118504/
https://www.ncbi.nlm.nih.gov/pubmed/27895692
http://dx.doi.org/10.3345/kjp.2016.59.11.446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118504/
https://www.ncbi.nlm.nih.gov/pubmed/27895692
http://dx.doi.org/10.3345/kjp.2016.59.11.446

Ejemplares similares